FR1922M - Nouveaux dérivés de vitamine b6 et leur utilisation thérapeutique. - Google Patents

Nouveaux dérivés de vitamine b6 et leur utilisation thérapeutique.

Info

Publication number
FR1922M
FR1922M FR900750A FR900750A FR1922M FR 1922 M FR1922 M FR 1922M FR 900750 A FR900750 A FR 900750A FR 900750 A FR900750 A FR 900750A FR 1922 M FR1922 M FR 1922M
Authority
FR
France
Prior art keywords
derivatives
therapeutic use
new vitamin
vitamin
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR900750A
Other languages
English (en)
Inventor
Robert Joseph Rene Dang
Robert Marius Carbonery
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROBERT
Original Assignee
ROBERT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROBERT filed Critical ROBERT
Priority to FR900750A priority Critical patent/FR1922M/fr
Application granted granted Critical
Publication of FR1922M publication Critical patent/FR1922M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR900750A 1962-06-14 1962-06-14 Nouveaux dérivés de vitamine b6 et leur utilisation thérapeutique. Expired FR1922M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR900750A FR1922M (fr) 1962-06-14 1962-06-14 Nouveaux dérivés de vitamine b6 et leur utilisation thérapeutique.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR900750A FR1922M (fr) 1962-06-14 1962-06-14 Nouveaux dérivés de vitamine b6 et leur utilisation thérapeutique.

Publications (1)

Publication Number Publication Date
FR1922M true FR1922M (fr) 1963-07-15

Family

ID=87570756

Family Applications (1)

Application Number Title Priority Date Filing Date
FR900750A Expired FR1922M (fr) 1962-06-14 1962-06-14 Nouveaux dérivés de vitamine b6 et leur utilisation thérapeutique.

Country Status (1)

Country Link
FR (1) FR1922M (fr)

Similar Documents

Publication Publication Date Title
BE619582A (fr) Tablettes thérapeutiques
AT271993B (de) Fungitoxisches Mittel
FR3041M (fr) Préparations vitaminiques.
AT263453B (de) Fungitoxisches Mittel
AT262695B (de) Fungitoxisches Mittel
FR2526M (fr) Médicament inhibiteur de la pyrocatechol-0-méthyltransferase.
FR2470M (fr) Composition thérapeutique.
FR2852M (fr) Préparations pharmaceutiques agissant sur le systeme nerveux central.
AT276855B (de) Fungitoxisches Mittel
FR1354736A (fr) Repose-pieds perfectionné
OA01031A (fr) Nouveaux composés hétérocycliques, leur préparation et leurs emplois.
CH487583A (de) Fungitoxisches Mittel
FR1922M (fr) Nouveaux dérivés de vitamine b6 et leur utilisation thérapeutique.
FR2755M (fr) Nouveaux agents thérapeutiques possédant l'activité de la vitamine b1.
OA01392A (fr) Nouveaux dérivés de la quinoléine et leur préparation.
FR1438608A (fr) Composés de la série de la vitamine alpha et leur préparation
FR1350973A (fr) Nouvelles acylmélamines polymérisables et leur préparation
FR1849M (fr) Nouveau médicament neurosédatif, hypnogene et relaxant musculaire.
FR2445M (fr) Nouveaux dérivés de la pipérazine, utilisables en thérapeutique.
FR2519M (fr) Médicament analgésique.
FR1336563A (fr) Nouveaux dérivés de dianthrone-éthylènes et leur préparation
FR1375300A (fr) Dérivés de benzophénone et leur préparation
OA02511A (fr) Oxadiazolidines, leur préparation et leur utilisation.
FR1296M (fr) Médicament d'action vitaminique p.
FR2622M (fr) Nouveaux composés thérapeutiques.